Skip to main content
Premium Trial:

Request an Annual Quote

In Brief This Week: PerkinElmer; Becton Dickinson; Premaitha Health; and More

NEW YORK (GenomeWeb) – PerkinElmer announced today that its board has declared a regular quarterly dividend of $.07 per share of common stock. The dividend is payable on May 10 to all shareholders of record at the close of business on Apr. 15.

Becton Dickinson also announced this week that its board has declared a quarterly dividend. BD will pay $.66 per common share on Mar. 31 to all shareholders of record on Mar. 10. This indicates an annual dividend rate of $2.64 per share, the company added.

Premaitha Health announced this week that it has signed two new service contracts with customers in Armenia and the Republic of Moldova for its clinical laboratory non-invasive prenatal screening service, Iona.

Sciex announced this week that it has signed a collaboration agreement with the Bioprocessing Technology Institute (BTI), a research institute under the auspices of Singapore's Agency for Science, Technology and Research (A*STAR). The organizations plan to work together to advance biologic therapeutics research and development in Singapore, including monoclonal antibodies and antibody drug conjugates. Under the terms of the deal, Sciex will provide BTI instruments such as the TripleTOF 6600 system and a Nano LC system, along with software and support from a team of application experts. BTI will, in turn, supply Sciex with data and validation results of methods developed in the course of the collaboration.

Life sciences technology holding company Predictive Technology Group announced this week that it acquired Nevada-based diagnostics developer LifeCode Genetics. Terms of the deal were not disclosed.

Harvard Business School this week kicked off the Precision Trials Challenge to generate new ideas for speeding up the clinical trials process for precision treatments and tests. The Challenge, announced last November at the Personalized Medicine Conference, will be led by HBS professors Richard Hamermesh and Robert Huckman. The winner will receive $50,000.

Enzo Biochem announced this week that it has received $7 million previously held in escrow relating to legal settlements from a patent infringement lawsuit the company filed in 2002 against PerkinElmer and Molecular Probes. The companies reached a settlement agreement in June 2014. Enzo said it will recognize the $7 million as a legal settlement gain in its consolidated statement of operations for the quarter ending Jan. 31.

In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on the GenomeWeb site.